Advertisement

Topics

Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing

05:30 EDT 23 Sep 2016 | Biotech-Finances

Thursday, September 22nd 2016 at 8:19pm UTC Findings Show Superiority of Flurpiridaz F 18 PET MPI Compared to SPECT MPI for the Assessment of Coronary Artery Disease During Exercise Stress Testing NORTH BILLERICA, Mass.–(BUSINESS WIRE)–  Lantheus Holdings, Inc. (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, …

Cet article Lantheus to Present New Data at the ASNC Annual Scientific Session
on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with
Suspected Heart Disease Undergoing Exercise Stress Testing
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing

NEXT ARTICLE

More From BioPortfolio on "Lantheus to Present New Data at the ASNC Annual Scientific Session on the Novel PET Cardiac Imaging Agent Flurpiridaz F 18 in Patients with Suspected Heart Disease Undergoing Exercise Stress Testing"

Quick Search
Advertisement
 

Relevant Topic

Stress
Stress is caused by your perception of situations around you and then the reaction of your body to them. The automatic stress response to unexpected events is known as 'fight or flight'. Discovered by Walter Cannon in 1932, it is the release of h...